79 results
8-K
EX-99.1
PRTA
Prothena Corporation plc
15 Feb 24
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
4:09pm
position in the amyloidosis community with ongoing enrollment of the confirmatory Phase 3 AFFIRM-AL clinical trial of birtamimab in patients
8-K
EX-99.1
k5bg66c2sy1
4 May 23
Prothena Reports First Quarter 2023 Financial Results and Business Highlights
4:08pm